Literature DB >> 13137632

Phenylbutazone (butazolidin), a useful chemotherapeutic agent for Hodgkin's disease.

A ROTTINO, A JOFFE, G HOFFMANN.   

Abstract

Entities:  

Keywords:  ANALGESICS/therapeutic use; HODGKIN'S DISEASE/therapy

Mesh：

Substances：

Year:  1954        PMID： 13137632     DOI： 10.1001/archinte.1954.00240280081009

Source DB:  PubMed          Journal:  AMA Arch Intern Med        ISSN： 0888-2479


× No keyword cloud information.
  3 in total

1.  [On butazolidin therapy of human hemoblastoses].

Authors:  K E HAMPEL; D ALGENSTAEDT; H GERHARTZ
Journal:  Blut       Date:  1961-12

2.  Rheumatic manifestations in Hodgkin's disease, leukaemia and allied conditions.

Authors:  E PAQUET; J M DELAGE
Journal:  Can Med Assoc J       Date:  1957-06-01       Impact factor: 8.262

3.  Clinical experience with phenylbutazone (Butazolidin).

Authors:  J B FRAIN; J E MORRIS
Journal:  Can Med Assoc J       Date:  1954-11       Impact factor: 8.262
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.